Safety and Effectiveness of Nintedanib in Korean Patients
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:March 12, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:March 12, 2024Completed
Condition(s):Atopic Dermatitis; Psoriasis; Alopecia; Mycosis Fungoides; Urticaria; Dermatoses; Stretch MarksLast Updated:May 22, 2015Terminated
Condition(s):Coronary Artery Disease; Inflammatory Response; AtherosclerosisLast Updated:December 21, 2007Terminated
Condition(s):Arteritis, Giant Cell; Blindness and Low VisionLast Updated:February 15, 2019Unknown status
Condition(s):Pulmonary Fibrosis of Any Cause; Primary Supporters/Caretakers of Patients With Pulmonary FibrosisLast Updated:March 13, 2019Completed
Condition(s):Calcinosis CutisLast Updated:November 17, 2016Withdrawn
Condition(s):Gastroesophageal Reflux Disease (GERD)Last Updated:April 29, 2015Withdrawn
Condition(s):ImmunosuppressionLast Updated:July 21, 2014Completed
Condition(s):Pulmonary Arterial Hypertension; Congenital Heart DiseaseLast Updated:August 16, 2017Unknown status
Condition(s):Graves’ OphthalmopathyLast Updated:September 15, 2005Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.